Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC.

Florent MalardMyriam LabopinChristina ChoDidier BlaiseEsperanza B PapadopoulosJakob PasswegRichard O'ReillyEdouard ForcadeMolly MaloyLiisa VolinHugo Castro-MalaspinaYosr HicheriAnn A JakubowskiCorentin OrvainSergio GiraltMohamad MohtyArnon NaglerMiguel-Angel Perales

Published in: Journal of hematology & oncology (2018)

These data suggest that both ex vivo CD34-selected and in vivo ATG T cell depletion are associated with a rather high OS and should be compared in a prospective randomized trial.

Keyphrases

stem cell transplantation
acute myeloid leukemia
high dose
electronic health record
allogeneic hematopoietic stem cell transplantation
disease activity
big data
free survival
low dose
ulcerative colitis
nk cells
rheumatoid arthritis
acute lymphoblastic leukemia
data analysis
artificial intelligence